potassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide

C43H47Cl2KN17O5- — CID 157196197

IUPACpotassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide
SMILESCC(C)(C)c1noc([C-]=O)n1.Cn1cc(Nc2ncnc(-c3ccc(CCC(=O)c4nc(C(C)(C)C)no4)c(Cl)c3)n2)cn1.Cn1cc(Nc2ncnc(-c3ccc(CN)c(Cl)c3)n2)cn1.[K+].[OH-]
InChIInChI=1S/C22H23ClN8O2.C14H14ClN7.C7H9N2O2.K.H2O/c1-22(2,3)20-29-19(33-30-20)17(32)8-7-13-5-6-14(9-16(13)23)18-24-12-25-21(28-18)27-15-10-26-31(4)11-15;1-22-7-11(6-19-22)20-14-18-8-17-13(21-14)9-2-3-10(5-16)12(15)4-9;1-7(2,3)6-8-5(4-10)11-9-6;;/h5-6,9-12H,7-8H2,1-4H3,(H,24,25,27,28);2-4,6-8H,5,16H2,1H3,(H,17,18,20,21);1-3H3;;1H2/q;;-1;+1;/p-1
InChIKeyOUGQOWFYUWXSOV-UHFFFAOYSA-M
MW991.97 g/mol
LogP3.94
Rot. Bonds12

About potassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide

potassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide (PubChem CID 157196197) has the molecular formula C43H47Cl2KN17O5- and a molecular weight of 991.97 g/mol. Its IUPAC name is potassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide.

Molecular Properties

Compound Namepotassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide
PubChem CID157196197
Molecular FormulaC43H47Cl2KN17O5-
Molecular Weight991.97 g/mol
Exact Mass990.30
IUPAC Namepotassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide
SMILESCC(C)(C)c1noc([C-]=O)n1.Cn1cc(Nc2ncnc(-c3ccc(CCC(=O)c4nc(C(C)(C)C)no4)c(Cl)c3)n2)cn1.Cn1cc(Nc2ncnc(-c3ccc(CN)c(Cl)c3)n2)cn1.[K+].[OH-]
InChIInChI=1S/C22H23ClN8O2.C14H14ClN7.C7H9N2O2.K.H2O/c1-22(2,3)20-29-19(33-30-20)17(32)8-7-13-5-6-14(9-16(13)23)18-24-12-25-21(28-18)27-15-10-26-31(4)11-15;1-22-7-11(6-19-22)20-14-18-8-17-13(21-14)9-2-3-10(5-16)12(15)4-9;1-7(2,3)6-8-5(4-10)11-9-6;;/h5-6,9-12H,7-8H2,1-4H3,(H,24,25,27,28);2-4,6-8H,5,16H2,1H3,(H,17,18,20,21);1-3H3;;1H2/q;;-1;+1;/p-1
InChIKeyOUGQOWFYUWXSOV-UHFFFAOYSA-M
XLogP3.94
TPSA305.04 Ų
H-Bond Donors3
H-Bond Acceptors22
Rotatable Bonds12
Heavy Atoms68
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500991.97
LogP ≤ 53.94
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze potassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of potassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide?
The IUPAC name of potassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide (CID 157196197) is potassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide.
What is the SMILES notation for potassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide?
The canonical SMILES for potassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide is CC(C)(C)c1noc([C-]=O)n1.Cn1cc(Nc2ncnc(-c3ccc(CCC(=O)c4nc(C(C)(C)C)no4)c(Cl)c3)n2)cn1.Cn1cc(Nc2ncnc(-c3ccc(CN)c(Cl)c3)n2)cn1.[K+].[OH-].
What is the InChIKey of potassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide?
The InChIKey is OUGQOWFYUWXSOV-UHFFFAOYSA-M. The full InChI is InChI=1S/C22H23ClN8O2.C14H14ClN7.C7H9N2O2.K.H2O/c1-22(2,3)20-29-19(33-30-20)17(32)8-7-13-5-6-14(9-16(13)23)18-24-12-25-21(28-18)27-15-10-26-31(4)11-15;1-22-7-11(6-19-22)20-14-18-8-17-13(21-14)9-2-3-10(5-16)12(15)4-9;1-7(2,3)6-8-5(4-10)11-9-6;;/h5-6,9-12H,7-8H2,1-4H3,(H,24,25,27,28);2-4,6-8H,5,16H2,1H3,(H,17,18,20,21);1-3H3;;1H2/q;;-1;+1;/p-1.
What are the key properties of potassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide?
potassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide has a molecular weight of 991.97 g/mol, XLogP of 3.94, 12 rotatable bonds, 3 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for potassium;4-[4-(aminomethyl)-3-chlorophenyl]-N-(1-methylpyrazol-4-yl)-1,3,5-triazin-2-amine;1-(3-tert-butyl-1,2,4-oxadiazol-5-yl)-3-[2-chloro-4-[4-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]phenyl]propan-1-one;(3-tert-butyl-1,2,4-oxadiazol-5-yl)methanone;hydroxide is sourced from PubChem (CID 157196197), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).